Skip to Main Content

Author Details

Brian R Shy
Gladstone-UCSF Institute of Genomic Immunology
2011
19
14
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38093011Base-editing mutagenesis maps alleles to tune human T cell functions.Nature2024
36008610High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails.Nat Biotechnol2023
36993276Dynamic phosphatase-recruitment controls B-cell selection and oncogenic signaling.bioRxiv2023
37147433Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.Nat Biomed Eng2023
35104875CRISPR-Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells.Nucleic Acids Res2022
35605882Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.Transplant Cell Ther2022
36350984Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies.Sci Transl Med2022
33399201Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.Am J Clin Pathol2021
33501951Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.Clin Infect Dis2021
34077734Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering.Cell Rep2021
32511477SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area.medRxiv2020
32943630SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.Nat Commun2020
32855547Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.Nat Biotechnol2020
32511497Test performance evaluation of SARS-CoV-2 serological assays.medRxiv2020
27484482Co-incident insertion enables high efficiency genome engineering in mouse embryonic stem cells.Nucleic Acids Res2016
23810553Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signaling.Cell Rep2013
22573616Function of Wnt/β-catenin in counteracting Tcf3 repression through the Tcf3-β-catenin interaction.Development2012
22689911MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.Brain2012
21685894Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal.Nat Cell Biol2011
  • 1 - 19 of 19

Recommended Authors

Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Institute for Medical Microbiology, Technical University of Munich (TUM)
Career Start Year 2009
Number of shared co-authors 12
University of Alabama at Birmingham Birmingham
Career Start Year 2009
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2008
Number of shared co-authors 9
University of Minnesota
Career Start Year 2007
Number of shared co-authors 0
Arc Institute
Career Start Year 2007
Number of shared co-authors 3
Boston Children's Hospital
Career Start Year 2006
Number of shared co-authors 3
St. Jude Children's Research Hospital.
Career Start Year 2006
Number of shared co-authors 1
Tokyo Metropolitan Institute of Medical Science, Japan Gladstone Institutes
Career Start Year 2006
Number of shared co-authors 1
Faculty of Medicine and University Hospital Carl Gustav Carus
Career Start Year 2005
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 1
University of California San Diego
Career Start Year 2004
Number of shared co-authors 3
Leidos Biomedical Research Inc.
Career Start Year 2003
Number of shared co-authors 0
Chinese Academy of Sciences
Career Start Year 2003
Number of shared co-authors 0
Wellcome Sanger Institute
Career Start Year 2003
Number of shared co-authors 0
Guy's and St Thomas' NHS Foundation Trust, Evelina Children's Hospital
Career Start Year 2001
Number of shared co-authors 0
Medical University of Vienna
Career Start Year 2001
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Stanford University Medical Center
Career Start Year 1997
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
The Florey Institute for Neuroscience and Mental Health, University of Melbourne
Career Start Year 1994
Number of shared co-authors 0
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Career Start Year 1990
Number of shared co-authors 0
Ottawa Hospital Research Institute
Career Start Year 1989
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 6
University Hospital Carl Gustav Carus, Technische Universitat (TU) Dresden
Career Start Year 1989
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 1
Stanford University
Career Start Year 1984
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 0
Exercise Medicine Research Institute, Edith Cowan University
Career Start Year 1973
Number of shared co-authors 1

Collaborators

Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 8
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 7
University of California san francisco
Co-authored papers 5
The Salk Institute for Biological Studies
Co-authored papers 5
Scientific Services
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
University of California San Francisco
Co-authored papers 5
University of California San Francisco School of Medicine
Co-authored papers 5
University of California-San Francisco
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
University of California San Francisco School of Medicine
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
University of CaliforniaSan Francisco
Co-authored papers 3
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 3
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Co-authored papers 2
University of California san francisco
Co-authored papers 2
San Francisco General Hospital, University of California
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California berkeley
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Vitalant Research Institute
Co-authored papers 2